GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (NEOE:FH) » Definitions » Interest Expense

Filament Health (NEOE:FH) Interest Expense : C$-0.24 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Filament Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Filament Health's interest expense for the three months ended in Dec. 2024 was C$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.24 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Filament Health's Operating Income for the three months ended in Dec. 2024 was C$ -1.09 Mil. Filament Health's Interest Expense for the three months ended in Dec. 2024 was C$ -0.01 Mil. Filament Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Filament Health Interest Expense Historical Data

The historical data trend for Filament Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health Interest Expense Chart

Filament Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
- -0.04 -0.19 -0.38 -0.24

Filament Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.11 -0.12 -0.01 -0.01

Filament Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Filament Health  (NEOE:FH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Filament Health's Interest Expense for the three months ended in Dec. 2024 was C$-0.01 Mil. Its Operating Income for the three months ended in Dec. 2024 was C$-1.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was C$0.09 Mil.

Filament Health's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Filament Health did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Filament Health Business Description

Traded in Other Exchanges
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
Executives
Benjamin Lightburn Director, Senior Officer
Thomas Kineshanko 10% Security Holder
Warren Duncan Senior Officer

Filament Health Headlines

No Headlines